Mario Gabelli Pfizer Inc Transaction History

Gamco Investors, Inc. Et Al

$8.56 Billion
Q2 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Pfizer Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 580,665 shares of PFE stock, worth $15.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

580,665

Previous 533,251 8.89%

Holding current value

$15.9 Million

Previous $14.8 Million 9.8%

% of portfolio

0.19%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $1.2 Million - $1.4 Million	47,414 Added 8.89%	580,665 $16.2 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $9.84 Million - $11.3 Million	380,046 Added 248.06%	533,251 $14.8 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $19,093 - $22,318	-595 Reduced 0.39%	153,205 $5.08 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $137,833 - $159,470	-3,816 Reduced 2.42%	153,800 $5.64 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $281,362 - $366,293	-7,143 Reduced 4.34%	157,616 $6.43 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $587,422 - $766,815	-14,070 Reduced 7.87%	164,759 $8.45 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $951,604 - $1.16 Million	-21,746 Reduced 10.84%	178,829 $7.83 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $366,516 - $434,574	7,877 Added 4.09%	200,575 $10.5 Million
Q1 2022 May 18, 2022	SELL	$45.75 - $56.69 $32,025 - $39,683	-700 Reduced 0.36%	192,698 $9.98 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $101,976 - $126,362	-2,229 Reduced 1.14%	193,398 $10 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $396,300 - $587,448	-9,591 Reduced 4.67%	195,627 $11.6 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $240,759 - $309,276	-6,134 Reduced 2.9%	205,218 $8.83 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $696,546 - $789,069	19,397 Added 10.1%	211,352 $8.28 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $201,710 - $227,488	-6,023 Reduced 3.04%	191,955 $6.96 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $630,206 - $801,362	-18,829 Reduced 8.68%	197,978 $7.29 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $604,520 - $709,240	-19,040 Reduced 8.07%	216,807 $7.96 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $2.03 Million - $2.46 Million	-67,337 Reduced 22.21%	235,847 $7.71 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $1.14 Million - $1.62 Million	42,073 Added 16.11%	303,184 $9.9 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $767,463 - $870,973	-23,313 Reduced 8.2%	261,111 $10.2 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $273,825 - $355,071	-8,428 Reduced 2.88%	284,424 $10.2 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $363,883 - $408,556	-9,840 Reduced 3.25%	292,852 $12.7 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $256,462 - $281,766	-6,839 Reduced 2.21%	302,692 $12.9 Million
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $433,941 - $494,740	-11,280 Reduced 3.52%	309,531 $13.5 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $743,483 - $901,799	-21,569 Reduced 6.3%	320,811 $14.1 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $1.49 Million - $1.59 Million	-45,121 Reduced 11.64%	342,380 $12.4 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $46,907 - $54,419	1,470 Added 0.38%	387,501 $13.8 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $3.03 Million - $3.21 Million	-91,095 Reduced 19.09%	386,031 $14 Million
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $14.8 Million - $16.3 Million	477,126	477,126 $17 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account